Ann: VIRALEZE relaunched by LloydsPharmacy in the UK, page-97

Can I get you opinion on the following:

1. The fact that the 'launch' conveniently occurred on the last day of the FY? Do you think there may have been a KPI tied to 'Launching' in the 21/22 FY? It just seems very convenient that the announcement occurred on THAT day when the actual launch did not occur until a few days later....
2. The FACT that the product is now NOT a COVID preventing device in the UK?
3. What impacts this rebranding in the UK will have on device registration and approvals in other regions? i.e. Is VIRALEZE going to be able to be advertised as a COVID preventing device anywhere now? There was a lot of talk early in the approvals process around the fact that governing bodies around the world tend to follow each others lead.

I really want to hear your opinion as I know it will take a positive spin on all of the above. Personally, I can't find a way to spin this into a positive.